|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$0.37 |
$0.45 |
$0.36 |
$0.44 |
6.42M | 03/22/2024 |
$0.45 |
$0.55 |
$0.45 |
$0.46 |
10.16M | 03/25/2024 |
$0.47 |
$0.50 |
$0.44 |
$0.46 |
3.71M | 03/26/2024 |
$0.46 |
$0.46 |
$0.39 |
$0.43 |
3.38M | 03/27/2024 |
$0.41 |
$0.43 |
$0.39 |
$0.41 |
1.57M |
|
TRACON Pharmaceuticals is a biopharmaceutical company. Co. has a collaboration and clinical trial agreement for the development of envafolimab, an investigational PD-L1 single-domain antibody for the treatment of sarcoma in North America. Co.'s other clinical stage oncology product candidates include YH001, which is a monospecific investigational cytotoxic T-lymphocyte-associated protein 4 antibody, TRC102, which is a small molecule that has been studied in Phase 1 and Phase 2 trials for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors, and TJ004309, which is a CD73 antibody in Phase 1 clinical development for the treatment of solid tumors. | |
|
TRACON Pharmaceuticals (TCON) has the following price history information. Looking back at TCON historical stock prices for the last five trading days, on March 21, 2024, TCON opened at $0.37, traded as high as $0.45 and as low as $0.36, and closed at $0.44. Trading volume was a total of 6.42M shares. On March 22, 2024, TCON opened at $0.45, traded as high as $0.55 and as low as $0.45, and closed at $0.46. Trading volume was a total of 10.16M shares. On March 25, 2024, TCON opened at $0.47, traded as high as $0.50 and as low as $0.44, and closed at $0.46. Trading volume was a total of 3.71M shares. On March 26, 2024, TCON opened at $0.46, traded as high as $0.46 and as low as $0.39, and closed at $0.43. Trading volume was a total of 3.38M shares. On March 27, 2024, TCON opened at $0.41, traded as high as $0.43 and as low as $0.39, and closed at $0.41. Trading volume was a total of 1.57M shares.
TCON Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into TRACON Pharmaceuticals shares, starting with a $10,000 purchase of TCON, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/02/2015 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$95.00 |
|
End price/share: |
$0.41 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.57% |
|
Average Annual Total Return: |
-44.85% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$43.15 |
|
Years: |
9.15 |
|
|
|
Date |
Close |
03/21/2024 | $0.44 | 03/22/2024 | $0.46 | 03/25/2024 | $0.46 | 03/26/2024 | $0.43 | 03/27/2024 | $0.41 |
|
|